{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:49:39Z","timestamp":1792090179911,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"UCSF Joint Radiation Oncology\/Radiology Seed Grant"},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH2210695"],"award-info":[{"award-number":["W81XWH2210695"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Conventional radiotherapy target delineation for glioblastoma (GBM) includes an isotropic expansion from gross tumor visible on anatomic MRI to an empirically defined clinical target volume (CTV) for coverage of microscopic infiltrative disease. GBM spreads preferentially along white matter tracts, but this information has not previously been systematically incorporated into radiotherapy planning. We investigated using white matter tractography from diffusion-weighted MRI (dwMRI) to inform target delineation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Thirteen patients with GBM underwent 55-directional dwMRI at the time of post-operative radiation planning MRI. Whole-brain tractography was performed, and streamlines passing within 5\u00a0mm of gross disease were used to generate maps representing white matter path length from gross disease. Clinical target volumes were generated using tractography (CTV\n                      <jats:sub>tract<\/jats:sub>\n                      ) and conventional isotropic expansion (CTV\n                      <jats:sub>isotropic<\/jats:sub>\n                      ). MRI at time of GBM recurrence was registered to the radiation planning MRI, and coverage of the recurrence volume was compared between CTV\n                      <jats:sub>tract<\/jats:sub>\n                      and CTV\n                      <jats:sub>isotropic<\/jats:sub>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CTV\n                      <jats:sub>tract<\/jats:sub>\n                      demonstrated non-isotropic expansion of the primary tumor along regional white matter tracts while respecting natural anatomic boundaries. CTV\n                      <jats:sub>tract<\/jats:sub>\n                      volumes using a 2\u00a0cm path-length were a median of 67\u00a0cc smaller (-19%) than the paired 2\u00a0cm CTV\n                      <jats:sub>isotropic<\/jats:sub>\n                      volumes (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003). 10\/13 recurrence volumes were included in CTV\n                      <jats:sub>isotropic<\/jats:sub>\n                      , while 12\/13 recurrence volumes were included in CTV\n                      <jats:sub>tract<\/jats:sub>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Tractography can be used to define CTV that may provide superior coverage of areas at risk of recurrence while simultaneously reducing target volume.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11060-026-05789-9","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:47:22Z","timestamp":1790333242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["White matter pathlength maps from diffusion-weighted MRI tractography for radiotherapy target planning in glioblastoma"],"prefix":"10.1007","volume":"179","author":[{"given":"Michael","family":"Wahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesshi","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland G.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier E.","family":"Villanueva-Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Theodosopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchel S.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Sneed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E.","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine M.","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"5789_CR1","first-page":"106","volume":"56","author":"A Jemal","year":"2006","unstructured":"Jemal A, Siegel R, Ward E, et al (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106\u2013130","journal-title":"CA Cancer J Clin"},{"key":"5789_CR2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466","journal-title":"Lancet Oncol"},{"key":"5789_CR3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.semradonc.2014.06.009","volume":"24","author":"S Fogh","year":"2014","unstructured":"Fogh S, Wahl M, Anwar M, Haas-Kogan D, Clarke JL, Sneed PK (2014) Standardization and quality assurance of radiation therapy volumes for adults with high-grade gliomas. Semin Radiat Oncol 24:259\u2013264","journal-title":"Semin Radiat Oncol"},{"key":"5789_CR4","doi-asserted-by":"crossref","unstructured":"Niyazi M et al (2016) ESTRO-ACROP guideline \u2018target delineation of glioblastomas\u2019. Radiother Oncol 118","DOI":"10.1016\/j.radonc.2015.12.003"},{"key":"5789_CR5","doi-asserted-by":"crossref","unstructured":"Niyazi M et al (2023) ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma. Radiother Oncol 184","DOI":"10.1016\/j.radonc.2023.109663"},{"key":"5789_CR6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.prro.2016.03.007","volume":"6","author":"AR Cabrera","year":"2016","unstructured":"Cabrera AR et al (2016) Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. Pract Radiat Oncol 6:217\u2013225","journal-title":"Pract Radiat Oncol"},{"key":"5789_CR7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.wneu.2017.04.053","volume":"103","author":"M Rapp","year":"2017","unstructured":"Rapp M et al (2017) Recurrence pattern analysis of primary glioblastoma. World Neurosurg 103:733\u2013740","journal-title":"World Neurosurg"},{"key":"5789_CR8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2010.08.020","volume":"97","author":"G Minniti","year":"2010","unstructured":"Minniti G, Amelio D, Amichetti M et al (2010) Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother Oncol 97:377\u2013381","journal-title":"Radiother Oncol"},{"key":"5789_CR9","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2008.19.4969","volume":"27","author":"AA Brandes","year":"2009","unstructured":"Brandes AA, Tosoni A, Franceschi E et al (2009) Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status. J Clin Oncol 27:1275\u20131279","journal-title":"J Clin Oncol"},{"key":"5789_CR10","doi-asserted-by":"crossref","first-page":"42148","DOI":"10.1038\/srep42148","volume":"7","author":"SH Choi","year":"2017","unstructured":"Choi SH, Kim JW, Chang JS et al (2017) Impact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy. Sci Rep 7:42148","journal-title":"Sci Rep"},{"key":"5789_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1748-717X-8-101","volume":"8","author":"LBE Shields","year":"2013","unstructured":"Shields LBE, Kadner R, Vitaz TW, Spalding AC (2013) Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme. Radiat Oncol 8:101","journal-title":"Radiat Oncol"},{"key":"5789_CR12","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ijrobp.2012.01.020","volume":"84","author":"DB Einstein","year":"2012","unstructured":"Einstein DB, Wessels B, Bangert B et al (2012) Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 84:668\u2013674","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5789_CR13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijrobp.2014.03.049","volume":"90","author":"NA Parra","year":"2014","unstructured":"Parra NA, Maudsley AA, Gupta RK et al (2014) Volumetric spectroscopic imaging of glioblastoma multiforme radiation treatment volumes. Int J Radiat Oncol Biol Phys 90:376\u2013384","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5789_CR14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijrobp.2014.06.009","volume":"90","author":"A Deviers","year":"2014","unstructured":"Deviers A, Ken S, Filleron T et al (2014) Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 90:385\u2013393","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5789_CR15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.radonc.2013.06.043","volume":"109","author":"S Rieken","year":"2013","unstructured":"Rieken S, Habermehl D, Giesel FL et al (2013) Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy. Radiother Oncol 109:487\u2013492","journal-title":"Radiother Oncol"},{"key":"5789_CR16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2010.09.020","volume":"82","author":"M Matsuo","year":"2012","unstructured":"Matsuo M, Miwa K, Tanaka O et al (2012) Impact of [11\u00a0C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning. Int J Radiat Oncol Biol Phys 82:83\u201389","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5789_CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.adro.2019.08.004","volume":"5","author":"S Miller","year":"2020","unstructured":"Miller S, Li P, Schipper M et al (2020) Metabolic Tumor Volume Response Assessment Using (11)C-Methionine Positron Emission Tomography Identifies Glioblastoma Tumor Subregions That Predict Progression Better Than Baseline or Anatomic Magnetic Resonance Imaging Alone. Adv Radiat Oncol 5:53\u201361","journal-title":"Adv Radiat Oncol"},{"key":"5789_CR18","doi-asserted-by":"crossref","first-page":"407026","DOI":"10.1155\/2014\/407026","volume":"2014","author":"K Miwa","year":"2014","unstructured":"Miwa K, Matsuo M, Ogawa S et al (2014) Hypofractionated high-dose irradiation with positron emission tomography data for the treatment of glioblastoma multiforme. Biomed Res Int 2014:407026","journal-title":"Biomed Res Int"},{"key":"5789_CR19","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.ijrobp.2021.03.032","volume":"110","author":"NN Laack","year":"2021","unstructured":"Laack NN, Pafundi D, Anderson SK et al (2021) Initial Results of a Phase 2 Trial of 18F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma. Int J Radiat Oncol Biol Phys 110:1383\u20131395","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5789_CR20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ijrobp.2018.04.045","volume":"102","author":"DR Wahl","year":"2018","unstructured":"Wahl DR, Kim MM, Aryal MP et al (2018) Combining Perfusion and High B-value Diffusion MRI to Inform Prognosis and Predict Failure Patterns in Glioblastoma. Int J Radiat Oncol Biol Phys 102:757\u2013764","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5789_CR21","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ijrobp.2021.01.033","volume":"110","author":"MM Kim","year":"2021","unstructured":"Kim MM, Sun Y, Aryal MP et al (2021) A Phase 2 Study of Dose-intensified Chemoradiation Using Biologically Based Target Volume Definition in Patients With Newly Diagnosed Glioblastoma. Int J Radiat Oncol Biol Phys 110:792\u2013803","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5789_CR22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.18383\/j.tom.2018.00035","volume":"5","author":"MM Kim","year":"2019","unstructured":"Kim MM, Parmar HA, Aryal MP et al (2019) Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma. Tomography 5:118\u2013126","journal-title":"Tomography"},{"key":"5789_CR23","first-page":"vdac006","volume":"4","author":"K Ramesh","year":"2022","unstructured":"Ramesh K, Mellon EA, Gurbani SS, Weinberg BD, Schreibmann E, Sheriff SA, Goryawala M, de le Fuente M, Eaton BR, Zhong J, Voloschin AD, Sengupta S, Dunbar EM, Holdhoff M, Barker PB, Maudsley AA, Kleinberg LR, Shim H, Shu HG (2022) A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma. Neurooncol Adv 4:vdac006","journal-title":"Neurooncol Adv"},{"key":"5789_CR24","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1038\/s41467-026-72545-y","volume":"17","author":"H Akbari","year":"2026","unstructured":"Akbari H, Mohan S, Liu F, Jiang C, Fathi Kazerooni A, Berger M, Rathore S, Bilello M, Sako C, Garcia J, Brem S, Bakas S, Mamourian E, Pepin A, James P, Dorsey J, Singh A, Parker D, Verma R, Cao Q, Bagley SJ, Desai A, O\u2019Rourke DM, Shinohara RT, Nasrallah MP, Teo BK, Kurtz G, Shukla G, Alonso-Basanta M, Lustig RA, Davatzikos C (2026) Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot study. Nat Commun 17:6413","journal-title":"Nat Commun"},{"key":"5789_CR25","first-page":"054001","volume":"11","author":"S Kwak","year":"2024","unstructured":"Kwak S, Akbari H, Garcia JA et al (2024) Predicting peritumoral glioblastoma infiltration and subsequent recurrence using deep-learning-based analysis of multi-parametric magnetic resonance imaging. J Med Imaging (Bellingham) 11:054001","journal-title":"J Med Imaging (Bellingham)"},{"key":"5789_CR26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1667\/RR14662.1","volume":"188","author":"M Anwar","year":"2017","unstructured":"Anwar M, Molinaro AM, Morin O et al (2017) Identifying voxels at risk for progression in glioblastoma based on dosimetry, physiologic and metabolic MRI. Radiat Res 188:303\u2013313","journal-title":"Radiat Res"},{"key":"5789_CR27","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ijrobp.2021.12.153","volume":"112","author":"Y Lao","year":"2022","unstructured":"Lao Y, Ruan D, Vassantachart A et al (2022) Voxelwise Prediction of Recurrent High-Grade Glioma via Proximity Estimation-Coupled Multidimensional Support Vector Machine. Int J Radiat Oncol Biol Phys 112:1279\u20131287","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5789_CR28","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41746-025-01861-2","volume":"8","author":"N Tran","year":"2025","unstructured":"Tran N, Luks TL, Li Y, Jakary A, Ellison J, Liu B, Adegbite O, Nair D, Kakhandiki P, Molinaro AM, Villanueva-Meyer JE, Butowski N, Clarke JL, Chang SM, Braunstein SE, Morin O, Lin H, Lupo JM (2025) Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRI. NPJ Digit Med 8:508","journal-title":"NPJ Digit Med"},{"key":"5789_CR29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3390\/brainsci15060576","volume":"15","author":"K Jang","year":"2025","unstructured":"Jang K, Back M (2025) Spatial Mapping of Glioblastoma Infiltration: Diffusion Tensor Imaging-Based Radiomics and Connectomics in Recurrence Prediction. Brain Sci 15:576","journal-title":"Brain Sci"},{"key":"5789_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11060-015-1928-5","volume":"125","author":"NJ Mickevicius","year":"2015","unstructured":"Mickevicius NJ, Carle AB, Bluemel T et al (2015) Location of brain tumor intersecting white matter tracts predicts patient prognosis. J Neurooncol 125:393\u2013400","journal-title":"J Neurooncol"},{"key":"5789_CR31","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1002\/mp.17640","volume":"52","author":"P Abbasian","year":"2025","unstructured":"Abbasian P, Ryner L, McCurdy B et al (2025) Predicting brain tumour growth patterns using a novel MRI-based tumour spread map: application to radiotherapy planning. Med Phys 52:2909\u20132921","journal-title":"Med Phys"},{"key":"5789_CR32","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.ijrobp.2008.04.017","volume":"71","author":"AP Krishnan","year":"2008","unstructured":"Krishnan AP, Asher IM, Davis D, Okunieff P, O\u2019Dell WG (2008) Evidence that MR diffusion tensor imaging (tractography) predicts the natural history of regional progression in patients irradiated conformally for primary brain tumors. Int J Radiat Oncol Biol Phys 71:1553\u20131562","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5789_CR33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/1754-9485.13873","volume":"69","author":"L Tian","year":"2025","unstructured":"Tian L, Wang W, Sun W et al (2025) Exploration of Diffusion Tensor Imaging for Delineating Target Volume Boundary in Glioblastoma Radiotherapy. J Med Imaging Radiat Oncol 69:601\u2013609","journal-title":"J Med Imaging Radiat Oncol"},{"key":"5789_CR34","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ijrobp.2015.02.058","volume":"92","author":"PP Pramanik","year":"2015","unstructured":"Pramanik PP, Parmar HA, Mammoser AG et al (2015) Hypercellularity Components of Glioblastoma Identified by High b-Value Diffusion-Weighted Imaging. Int J Radiat Oncol Biol Phys 92:811\u2013819","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5789_CR35","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00066-014-0676-3","volume":"190","author":"J Berberat","year":"2014","unstructured":"Berberat J, McNamara J, Remonda L, Bodis S, Rogers S (2014) Diffusion tensor imaging for target volume definition in glioblastoma multiforme. Strahlenther Onkol 190:939\u2013943","journal-title":"Strahlenther Onkol"},{"key":"5789_CR36","doi-asserted-by":"crossref","first-page":"8718097","DOI":"10.1155\/2020\/8718097","volume":"2020","author":"Q Fei","year":"2020","unstructured":"Fei Q, Qian LX, Zhang YJ et al (2020) The Utility of Diffusion and Perfusion Magnetic Resonance Imaging in Target Delineation of High-Grade Gliomas. Biomed Res Int 2020:8718097","journal-title":"Biomed Res Int"},{"key":"5789_CR37","doi-asserted-by":"crossref","first-page":"20190441","DOI":"10.1259\/bjr.20190441","volume":"93","author":"R Rahmat","year":"2020","unstructured":"Rahmat R, Brochu F, Li C, Sinha R, Price SJ, Jena R (2020) Semi-automated construction of patient individualised clinical target volumes for radiotherapy treatment of glioblastoma utilising diffusion tensor decomposition maps. Br J Radiol 93:20190441","journal-title":"Br J Radiol"},{"key":"5789_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11060-025-05050-9","volume":"174","author":"S Marino","year":"2025","unstructured":"Marino S, Menna G, Doglietto F, Quaranta D, Chiesa S, Gaudino S, Russo R, Marziali G, Galeazzi M, D\u2019Alessandris QG, Lauretti L, Mattogno PP, Di Bonaventura R, Caraglia N, Di Maio L, Olivi A, Della Pepa GM (2025) A white matter-centered approach to investigate recurrence pathways in high-grade gliomas: a single-center retrospective study. J Neurooncol 174:177\u2013190","journal-title":"J Neurooncol"},{"key":"5789_CR39","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3389\/fonc.2019.00810","volume":"9","author":"K Jordan","year":"2019","unstructured":"Jordan K, Morin O, Wahl M, Amirbekian B, Chapman C, Owen J, Mukherjee P, Braunstein S, Henry R (2019) An Open-Source Tool for Anisotropic Radiation Therapy Planning in Neuro-oncology Using DW-MRI Tractography. Front Oncol 9:810","journal-title":"Front Oncol"},{"key":"5789_CR40","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"M Jenkinson","year":"2012","unstructured":"Jenkinson M, Beckmann CF, Behrens TE et al (2012) FSL Neuroimage 62:782\u2013790","journal-title":"FSL Neuroimage"},{"key":"5789_CR41","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/mrm.21890","volume":"61","author":"A Leemans","year":"2009","unstructured":"Leemans A, Jones DK (2009) The B-matrix must be rotated when correcting for subject motion in DTI data. Magn Reson Med 61:1336\u20131349","journal-title":"Magn Reson Med"},{"key":"5789_CR42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fninf.2014.00008","volume":"8","author":"E Garyfallidis","year":"2014","unstructured":"Garyfallidis E, Brett M, Amirbekian B, Rokem A, van der Walt S, Descoteaux M, Nimmo-Smith I, Dipy C (2014) Dipy, a library for the analysis of diffusion MRI data. Front Neuroinform 8:8","journal-title":"Front Neuroinform"},{"key":"5789_CR43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuroimage.2007.08.021","volume":"39","author":"JI Berman","year":"2008","unstructured":"Berman JI, Chung S, Mukherjee P, Hess CP, Han ET, Henry RG (2008) Probabilistic streamline q-ball tractography using the residual bootstrap. NeuroImage 39:215\u2013222","journal-title":"NeuroImage"},{"key":"5789_CR44","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuroimage.2009.04.049","volume":"47","author":"A Tristan-Vega","year":"2009","unstructured":"Tristan-Vega A, Westin CF, Aja-Fernandez S (2009) Estimation of fiber orientation probability density functions in high angular resolution diffusion imaging. NeuroImage 47:638\u2013650","journal-title":"NeuroImage"},{"key":"5789_CR45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.media.2009.11.001","volume":"14","author":"A Tristan-Vega","year":"2010","unstructured":"Tristan-Vega A, Aja-Fernandez S (2010) DWI filtering using joint information for DTI and HARDI. Med Image Anal 14:205\u2013218","journal-title":"Med Image Anal"},{"key":"5789_CR46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.nicl.2013.08.008","volume":"3","author":"M Bucci","year":"2013","unstructured":"Bucci M, Mandelli ML, Berman JI, Amirbekian B, Nguyen C, Berger MS, Henry RG (2013) Quantifying diffusion MRI tractography of the corticospinal tract in brain tumors with deterministic and probabilistic methods. Neuroimage Clin 3:361\u2013368","journal-title":"Neuroimage Clin"},{"key":"5789_CR47","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.30.9.907","volume":"30","author":"FH Hochberg","year":"1980","unstructured":"Hochberg FH, Pruitt A (1980) Assumptions in the radiotherapy of glioblastoma. Neurology 30:907\u2013911","journal-title":"Neurology"},{"key":"5789_CR48","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S1474-4422(09)70204-2","volume":"8","author":"L Douw","year":"2009","unstructured":"Douw L, Klein M, Fagel SS et al (2009) Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol 8:810\u2013818","journal-title":"Lancet Neurol"},{"key":"5789_CR49","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1088\/0031-9155\/59\/3\/771","volume":"59","author":"J Unkelbach","year":"2014","unstructured":"Unkelbach J, Menze BH, Konukoglu E, Dittmann F, Ayache N, Shih HA (2014) Radiotherapy planning for glioblastoma based on a tumor growth model: implications for spatial dose redistribution. Phys Med Biol 59:771\u2013789","journal-title":"Phys Med Biol"},{"key":"5789_CR50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.media.2011.10.001","volume":"16","author":"P Mosayebi","year":"2012","unstructured":"Mosayebi P, Cobzas D, Murtha A, Jagersand M (2012) Tumor invasion margin on the Riemannian space of brain fibers. Med Image Anal 16:361\u2013373","journal-title":"Med Image Anal"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05789-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05789-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05789-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:01:40Z","timestamp":1792087300000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05789-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5789"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05789-9","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"13 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from all patients included in this IRB-approved study.","order":1,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"102"}}